Search Results - "Marchica, Valentina"

Refine Results
  1. 1
  2. 2

    Oncolytic Virotherapy and Microenvironment in Multiple Myeloma by Marchica, Valentina, Costa, Federica, Donofrio, Gaetano, Giuliani, Nicola

    “…Multiple myeloma (MM) is a hematologic malignancy characterized by the accumulation of bone marrow (BM) clonal plasma cells, which are strictly dependent on…”
    Get full text
    Journal Article
  3. 3

    Role of Galectins in Multiple Myeloma by Storti, Paola, Marchica, Valentina, Giuliani, Nicola

    “…Galectins are a family of lectins that bind β-galactose-containing glycoconjugates and are characterized by carbohydrate-recognition domains (CRDs). Galectins…”
    Get full text
    Journal Article
  4. 4
  5. 5

    CD14+CD16+ monocytes are involved in daratumumab‐mediated myeloma cells killing and in anti‐CD47 therapeutic strategy by Storti, Paola, Vescovini, Rosanna, Costa, Federica, Marchica, Valentina, Toscani, Denise, Dalla Palma, Benedetta, Craviotto, Luisa, Malavasi, Fabio, Giuliani, Nicola

    Published in British journal of haematology (01-08-2020)
    “…Summary A deep elucidation of the mechanisms of action of anti‐CD38 monoclonal antibodies (mAbs), such as daratumumab (DARA), is required to identify patients…”
    Get full text
    Journal Article
  6. 6
  7. 7

    A Simplified SARS-CoV-2 Pseudovirus Neutralization Assay by Donofrio, Gaetano, Franceschi, Valentina, Macchi, Francesca, Russo, Luca, Rocci, Anna, Marchica, Valentina, Costa, Federica, Giuliani, Nicola, Ferrari, Carlo, Missale, Gabriele

    Published in Vaccines (Basel) (15-04-2021)
    “…COVID-19 is an ongoing pandemic caused by the highly infectious coronavirus SARS-CoV-2 that is engaging worldwide scientific research to find a timely and…”
    Get full text
    Journal Article
  8. 8

    Molecular Features of the Mesenchymal and Osteoblastic Cells in Multiple Myeloma by Iannozzi, Nicolas Thomas, Marchica, Valentina, Toscani, Denise, Burroughs Garcìa, Jessica, Giuliani, Nicola, Storti, Paola

    “…Multiple myeloma (MM) is a monoclonal gammopathy characterized by biological heterogeneity and unregulated proliferation of plasma cells (PCs) in bone marrow…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Angiopoietin 1 and integrin beta 1b are vital for zebrafish brain development by Chen, Yu-Chia, Martins, Tomás A, Marchica, Valentina, Panula, Pertti

    Published in Frontiers in cellular neuroscience (03-01-2024)
    “…Angiopoietin 1 (angpt1) is essential for angiogenesis. However, its role in neurogenesis is largely undiscovered. This study aimed to identify the role of…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Metabolic features of myeloma cells in the context of bone microenvironment: Implication for the pathophysiology and clinic of myeloma bone disease by Raimondi, Vincenzo, Toscani, Denise, Marchica, Valentina, Burroughs-Garcia, Jessica, Storti, Paola, Giuliani, Nicola

    Published in Frontiers in oncology (13-10-2022)
    “…Multiple myeloma (MM) is a hematological malignancy characterized by the accumulation of malignant plasma cells (PCs) into the bone marrow (BM). The complex…”
    Get full text
    Journal Article
  13. 13

    Mechanisms of Action of the New Antibodies in Use in Multiple Myeloma by Romano, Alessandra, Storti, Paola, Marchica, Valentina, Scandura, Grazia, Notarfranchi, Laura, Craviotto, Luisa, Di Raimondo, Francesco, Giuliani, Nicola

    Published in Frontiers in oncology (08-07-2021)
    “…Monoclonal antibodies (mAbs) directed against antigen-specific of multiple myeloma (MM) cells have Fc-dependent immune effector mechanisms, such as…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19

    Role of 1q21 in Multiple Myeloma: From Pathogenesis to Possible Therapeutic Targets by Burroughs Garcìa, Jessica, Eufemiese, Rosa Alba, Storti, Paola, Sammarelli, Gabriella, Craviotto, Luisa, Todaro, Giannalisa, Toscani, Denise, Marchica, Valentina, Giuliani, Nicola

    Published in Cells (Basel, Switzerland) (01-06-2021)
    “…Multiple myeloma (MM) is characterized by an accumulation of malignant plasma cells (PCs) in the bone marrow (BM). The amplification of 1q21 is one of the most…”
    Get full text
    Journal Article
  20. 20